Tobii’s industry-leading eye-tracking technology will be utilized to provide innovative gaze-directed interface for ControlRad’s radiation reduction solutions.

PHILADELPHIA, PA – October. 30, 2018 – ControlRad, Inc., a medical technology company focused on dramatically reducing unnecessary radiation exposure to patients and physicians during fluoroscopic procedures, announced today a partnership with Stockholm-based Tobii AB, the world leader in eye-tracking technology. Tobii will be the exclusive source of ControlRad’s eye-tracker interface for its solution that provides up to 75% radiation reduction technology without reducing image quality or impacting provider workflow.


ControlRad’s technology reduces the radiation dose exposure to the patient and operators by approximately 75 percent.

PHILADELPHIA, PA – [March 2018] – ControlRad, Inc. announced today that it has expanded its patent portfolio to 18 patents covering their innovative radiation dose reduction technologies which dramatically reduce unnecessary radiation exposure to both patients and medical staff.


Study demonstrating 75 percent reduction in operator radiation exposure published in Medical Physics

PHILADELPHIA, PA – March 31, 2016 – ControlRad announced that definitive results from an in vivo evaluation of its proprietary solution to considerably reduce patient and medical staff exposure to ionizing radiation during fluoroscopically guided interventional procedures (FGIP) have been published in the peer-reviewed journal Medical Physics. 1


Image

EMAIL NEWSLETTER

Sign up for our mailing list to get the latest ControlRad news.

Please let us know your name.
Please let us know your email address.
Invalid Input

LATEST NEWS

DOWNLOADS

Download Brochure